» Articles » PMID: 6322890

Ryanodine Prolongs Ca-currents While Suppressing Contraction in Rat Ventricular Muscle Cells

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1984 Jan 1
PMID 6322890
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Ryanodine (1 microM) suppressed or abolished contraction in response to step depolarization in voltage-clamped cells isolated from adult rat ventricular myocardium. The step depolarizations evoked the second inward current, which is carried largely by Ca ions under these conditions, and there was little or no change in the amplitude of this current when contraction was reduced or abolished by ryanodine. The effects of ryanodine on contraction were, however, accompanied by a prolongation of the second inward current resulting from a slowing of the apparent inactivation of this current. It is suggested that ryanodine affects steps in excitation-contraction coupling subsequent to the second inward current, perhaps Ca-release from intracellular stores, and that this slows a Ca-dependent inactivation of second inward current.

Citing Articles

Inactivation of ICa-L is the major determinant of use-dependent facilitation in rat cardiomyocytes.

Guo J, Duff H J Physiol. 2003; 547(Pt 3):797-805.

PMID: 12562907 PMC: 2342727. DOI: 10.1113/jphysiol.2002.033340.


Voltage- and cation-dependent inactivation of L-type Ca2+ channel currents in guinea-pig ventricular myocytes.

Findlay I J Physiol. 2002; 541(Pt 3):731-40.

PMID: 12068036 PMC: 2290374. DOI: 10.1113/jphysiol.2002.019729.


Overview of voltage-dependent calcium channels.

Jones S J Bioenerg Biomembr. 1998; 30(4):299-312.

PMID: 9758327 DOI: 10.1023/a:1021977304001.


The role of Ca2+ release from sarcoplasmic reticulum in the regulation of sinoatrial node automaticity.

Hata T, Noda T, Nishimura M, Watanabe Y Heart Vessels. 1996; 11(5):234-41.

PMID: 9129243 DOI: 10.1007/BF01746203.


Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols.

Campbell D, Stamler J, Strauss H J Gen Physiol. 1996; 108(4):277-93.

PMID: 8894977 PMC: 2229328. DOI: 10.1085/jgp.108.4.277.


References
1.
JENDEN D, Fairhurst A . The pharmacology of ryanodine. Pharmacol Rev. 1969; 21(1):1-25. View

2.
PENEFSKY Z . Ultrastructural studies of the site of action of ryanodine on heart muscle. Pflugers Arch. 1974; 347(3):185-98. DOI: 10.1007/BF00592596. View

3.
Sutko J, Willerson J, Templeton G, Jones L, Besch Jr H . Ryanodine: its alterations of cat papillary muscle contractile state and responsiveness to inotropic interventions and a suggested mechanism of action. J Pharmacol Exp Ther. 1979; 209(1):37-47. View

4.
Fabiato A, Fabiato F . Calcium and cardiac excitation-contraction coupling. Annu Rev Physiol. 1979; 41:473-84. DOI: 10.1146/annurev.ph.41.030179.002353. View

5.
Sutko J, Willerson J . Ryanodine alteration of the contractile state of rat ventricular myocardium. Comparison with dog, cat, and rabbit ventricular tissues. Circ Res. 1980; 46(3):332-43. DOI: 10.1161/01.res.46.3.332. View